GlobeNewswire 09-22 Dupixent® (dupilumab) to Treat Chronic Spontaneous Urticaria (CSU) Advances in EU with Positive CHMP...
GlobeNewswire 09-19 Alvotech Announces Marketing Approval in Japan of Three New Biosimilars
GlobeNewswire 09-19 Regeneron Donates Ebola Treatment for Use in Countries Most at Risk of Outbreaks
GlobeNewswire 09-17 Results from Phase 2 COURAGE Trial Demonstrating Potential to Improve Quality of GLP-1 receptor agon...
GlobeNewswire 09-17 AskBio Announces Completion of Enrollment in Phase 1 Clinical Trial of AB-1005 Gene Therapy for Mult...
GlobeNewswire 09-17 Regeneron Announces Positive Phase 3 Trial in Adults with Ultra-Rare Genetic Disorder Fibrodysplasia...
GlobeNewswire 09-16 Expert with Bayer Discusses the U.S. Launch of Aspirina Families with YourUpdateTV
GlobeNewswire 09-16 Parexel Announces Appointment of Rob Goodwin as Chief Operating Officer
GlobeNewswire 09-16 Indicium Receives Investment from Databricks Ventures
TeleTrader 09-11 Europe closes higher after ECB decision
GlobeNewswire 09-10 Dewpoint Therapeutics Closes Series D Financing to Advance First-in-Class Condensate Modulator (c-mo...
GlobeNewswire 09-09 Libtayo® (cemiplimab) Plus Chemotherapy Results at Five Years Reinforce Significant and Durable Impr...
GlobeNewswire 09-08 DIH Appoints Barrett Mooney, Ph.D to DIH Holding US, Inc. Board of Directors 
GlobeNewswire 09-08 Regeneron Advances Allergy Pipeline with Two Positive Phase 3 Trials Evaluating First-in-Class Antib...
GlobeNewswire 09-08 CHARM Therapeutics Appoints Dr Erkut Bahceci as Chief Medical Officer
GlobeNewswire 09-04 Mark your calendars. CIOs invited to HMG Strategy’s Bringing Structure to AI free webinar on Septemb...
GlobeNewswire 09-02 Definitive Feasibility Study Results and Reserves Upgrade Confirms Minim Martap as a Tier-One Bauxit...
GlobeNewswire 08-30 Acoramidis Demonstrates Statistically Significant Reduction in Cardiovascular Mortality (CVM) throug...
GlobeNewswire 08-26 Final 2 Days to Register! St. Louis C-suite executives invited to HMG Strategy’s 11th Annual C-Level...
GlobeNewswire 08-26 Clearing Organizational Roadblocks That Keep You From Doing Your Job
GlobeNewswire 08-26 Regeneron Announces Positive Results from Phase 3 Trial in Generalized Myasthenia Gravis
GlobeNewswire 08-21 Advanz Pharma and Alvotech receive European approval for Mynzepli®, Biosimilar to Eylea®
GlobeNewswire 08-20 EYLEA HD® (aflibercept) Injection 8 mg Applications for Expanded U.S. Label and Prefilled Syringe Re...
GlobeNewswire 08-20 genXtraits Inc. and Mendel Biotechnology, Inc. enter collaboration
GlobeNewswire 08-15 Mark your calendars! St. Louis C-suite executives invited to HMG Strategy’s 11th Annual C-Level Tech...